TY - JOUR
T1 - Sequential liver-kidney transplantation in a boy with congenital hepatic fibrosis and nephronophthisis from a living donor
AU - Udagawa, Tomohiro
AU - Kamei, Koichi
AU - Ogura, Masao
AU - Tsutsumi, Akiko
AU - Noda, Shunsuke
AU - Kasahara, Mureo
AU - Fukuda, Akinari
AU - Sakamoto, Seisuke
AU - Shigeta, Shigenobu
AU - Tanaka, Hideaki
AU - Kuroda, Tatsuo
AU - Matsuoka, Kentarou
AU - Nakazawa, Atuko
AU - Nagai, Takuto
AU - Uemura, Osamu
AU - Ito, Shuichi
PY - 2012/11
Y1 - 2012/11
N2 - A five-yr-old boy developed chronic liver failure and ESKD because of CHF and juvenile NPHP. He underwent sequential liver and kidney transplantation with a compatible blood type from his father, at five yr, seven months and five yr, 11 months old, respectively. Because the patient was not in ESKD, we initially performed LDLT because of significant portal hypertension. Even after LDLT, his ascites was not ameliorated, and he needed continuous drainage of ascites and daily albumin and gamma globulin infusion. Thereafter, he progressed to ESKD and needed hemodialysis for one month before LDKT. CDC crossmatch for donor B cells in the warm test, FCXM for B cell IgG, and flow PRA for donor class II were positive before LDKT. After pretreatment of three courses of plasma exchange and intravenous gamma globulin, LDKT was performed. Two weeks after LDKT, AIHA concomitant with autoimmune thrombocytopenia, also called Evans syndrome, occurred because of passenger lymphocytes from the donor; however, the patient was successfully treated with intravenous methylprednisolone. Eighteen months have passed since LDKT, and liver and kidney function in both the recipient and donor are normal.
AB - A five-yr-old boy developed chronic liver failure and ESKD because of CHF and juvenile NPHP. He underwent sequential liver and kidney transplantation with a compatible blood type from his father, at five yr, seven months and five yr, 11 months old, respectively. Because the patient was not in ESKD, we initially performed LDLT because of significant portal hypertension. Even after LDLT, his ascites was not ameliorated, and he needed continuous drainage of ascites and daily albumin and gamma globulin infusion. Thereafter, he progressed to ESKD and needed hemodialysis for one month before LDKT. CDC crossmatch for donor B cells in the warm test, FCXM for B cell IgG, and flow PRA for donor class II were positive before LDKT. After pretreatment of three courses of plasma exchange and intravenous gamma globulin, LDKT was performed. Two weeks after LDKT, AIHA concomitant with autoimmune thrombocytopenia, also called Evans syndrome, occurred because of passenger lymphocytes from the donor; however, the patient was successfully treated with intravenous methylprednisolone. Eighteen months have passed since LDKT, and liver and kidney function in both the recipient and donor are normal.
KW - Evans syndrome
KW - congenital hepatic fibrosis
KW - living donor kidney transplant
KW - living donor liver transplantation
KW - nephronophthisis
KW - sequential liver-kidney transplantation
UR - http://www.scopus.com/inward/record.url?scp=84866732895&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866732895&partnerID=8YFLogxK
U2 - 10.1111/j.1399-3046.2011.01611.x
DO - 10.1111/j.1399-3046.2011.01611.x
M3 - Article
C2 - 22129440
AN - SCOPUS:84866732895
SN - 1397-3142
VL - 16
SP - E275-E280
JO - Pediatric Transplantation
JF - Pediatric Transplantation
IS - 7
ER -